Title: Methods of Treating Meiotic Kinesin-associated Disease
Patent Number: 8,629,118
Filed: April 7, 2011
Inventor: David Pellman, Dana-Farber Cancer Institute
Title: Dual Targeting of miR-208 and miR-499 in the Treatment of Cardiac Disorders
Patent Number: 8,629,119
Filed: Feb. 4, 2010
Lead Inventor: Eric Olson, University of Texas (Miragen Therapeutics)
Title: Plant Nucleic Acids Associated with Cellular pH and Uses Thereof
Patent Number: 8,629,258
Filed: June 4, 2009
Lead Inventor: Francesca Quattrocchio, VU University Amsterdam